Market Data
AYES: AYES ÇELİK HASIR VE ÇİT SANAYİ A.Ş. Stock Live Price Graph
Company profile
Market News & Analysis
Target Price
No analyst target price data is available for this instrument.
Dividend History
Cash dividends
| Payment | Gross / share | Net / share | Yield | Per 1,000 TRY |
|---|---|---|---|---|
| May 31, 2026 | TRY 0.3 | TRY 0.35 | 35.29% | TRY 52,941,165 |
| Jul 6, 2025 | TRY 0.08 | TRY 0.09 | 8.82% | TRY 13,236,000 |
| Sep 1, 2024 | TRY 0.27 | TRY 0.3 | 30.00% | TRY 9,016,920 |
Splits & capital actions
| Date | Ratio | Bonus % | Rights % | Dividend % |
|---|---|---|---|---|
| May 31, 2026 | 1.0105 | 0% | 0% | 35.29411% |
| Jul 6, 2025 | 1.00627 | 0% | 0% | 8.82352% |
| Sep 23, 2024 | 4.99062 | 399.06176% | 0% | 0% |
| Sep 1, 2024 | 1.00727 | 0% | 0% | 30% |
| May 31, 2023 | 1.01304 | 0% | 0% | 24.44445% |
| Jan 9, 2023 | 2 | 100% | 0% | 0% |
| May 31, 2022 | 1.00968 | 0% | 0% | 20% |
| May 10, 2021 | 1.00624 | 0% | 0% | 15% |
| Jan 3, 2021 | 1.00441 | 0% | 0% | 5% |
| May 27, 2019 | 1.03247 | 0% | 0% | 5% |
| Jun 4, 2018 | 1.03763 | 0% | 0% | 7% |
| Jun 4, 2017 | 1.03226 | 0% | 0% | 5% |
| Jun 5, 2016 | 1.05 | 0% | 0% | 5% |
| May 31, 2015 | 1.05618 | 0% | 0% | 5% |
| Jun 1, 2014 | 1.0641 | 0% | 0% | 5% |
| Jul 14, 2013 | 1.03448 | 0% | 0% | 5% |
Upcoming corporate actions
| Date | Ratio | Bonus % | Rights % | Dividend % |
|---|---|---|---|---|
| - | - | 0% | 0% | - |
What Is AYES? Live AYES Prices and Analysis
AYES, or Aytu BioPharma, Inc., is a publicly traded company focused on the development and commercialization of innovative therapeutics and consumer healthcare products. As a player in the biopharmaceutical sector, AYES holds significant importance in modern healthcare, particularly in addressing unmet medical needs. Investors closely monitor AYES due to its potential for growth and innovation in a rapidly evolving industry.
The stock is often a topic of interest among investors looking to capitalize on advancements in biotechnology and pharmaceuticals. Its performance can be indicative of broader trends in the healthcare sector, making it a valuable asset for portfolio diversification.
With the ongoing developments in healthcare and the increasing demand for effective treatments, AYES represents a compelling opportunity for investors. The company’s focus on developing solutions for critical health issues positions it well in the market.
Market Context
AYES operates in a dynamic market characterized by international trading and varying pricing currencies. The volatility of the biopharmaceutical sector can be influenced by numerous factors, including regulatory approvals, clinical trial results, and market competition. As AYES navigates these challenges, its stock price can experience significant fluctuations, which investors need to consider when trading.
Why Do AYES Prices Rise or Fall?
The stock price of AYES can be influenced by a myriad of factors that reflect both internal and external market conditions. Understanding these factors is crucial for potential investors looking to make informed decisions.
- Clinical trial results: Positive or negative outcomes can significantly impact stock prices.
- Regulatory approvals: Securing FDA approval can lead to substantial increases in stock value.
- Market competition: The entry of new competitors can affect AYES's market share and pricing power.
- Partnerships and collaborations: Strategic alliances can enhance AYES’s capabilities and market reach.
- Earnings reports: Quarterly earnings can provide insights into the company's financial health and growth potential.
- Investor sentiment: Market perception and news can sway stock prices, often irrespective of fundamentals.
- Economic indicators: Broader economic conditions can influence investor confidence and spending in healthcare.
- Technological advancements: Innovations in biotechnology can create new opportunities or challenges for AYES.
In summary, the stock price of AYES is subject to various influences that can create both opportunities and risks for investors. Understanding these dynamics is essential for making informed trading decisions.
Why Is Live AYES Price Tracking Important?
Tracking the live price of AYES is crucial for investors seeking to capitalize on market movements and make timely decisions. The volatility of biotech stocks means that prices can change rapidly, and being informed can provide a competitive advantage.
- Real-time insights: Investors can react quickly to market changes.
- Trend analysis: Monitoring price movements helps identify potential trends.
- Risk management: Understanding price volatility assists in managing investment risks.
- Investment timing: Live tracking aids in determining optimal entry and exit points.
- Market sentiment: Prices reflect investor confidence and market conditions.
What Should You Consider When Trading / Investing in AYES?
Investing in AYES carries inherent risks and rewards that potential investors should carefully evaluate. The biopharmaceutical sector is known for its volatility, and AYES is no exception. Key considerations include:
- Market volatility: Be prepared for significant price fluctuations.
- Regulatory risks: Changes in regulations can impact AYES’s operations and profitability.
- Research data: Stay informed about clinical trial results and their implications.
- Financial health: Regularly review AYES’s earnings reports and balance sheets.
- Sector trends: Monitor developments in the biotechnology and pharmaceutical industries.
What Can You Find on the Investvio AYES Page?
- Live price updates: Stay informed with real-time stock prices.
- Interactive charts: Analyze historical price movements and trends.
- Technical analysis: Access tools for evaluating stock performance.
- Market news: Read the latest updates and announcements related to AYES.
- Earnings reports: Review detailed financial statements and performance metrics.
In conclusion, AYES presents a unique investment opportunity within the biopharmaceutical sector. By utilizing the resources available on the Investvio AYES page, investors can stay informed and make educated decisions regarding their investments in this dynamic market.